Determining the optimal interval between neoadjuvant radiochemotherapy and surgery in rectal cancer: a retrospective cohort study

[1] Bosset JF(2006)EORTC Radiotherapy Group Trial 22921: Chemotherapy with preoperative radiotherapy in rectal cancer New Engl J Med 355 1114-1123

[2] Collette L(2006)Preoperative radiotherapy with ´ or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 4620-4625

[3] Calais G(2011)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12- year follow-up of the multicentre, randomised controlled TME trial Lancet Oncol 12 575-582

[4] Gerard JP(2005)Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 5644-5650

[5] Conroy T(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[6] Bonnetain F(2012)Preoperative versus postoperative chemoradiotherapy for localy advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933

[7] Van Gijn W(2018)Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer J Surg Res 226 15-23

[8] Marijnen CA(1999)Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90–01 randomized trial J Clin Oncol 17 2396-553

[9] Nagtegaal ID(2016)Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90–01 Randomized Trial Int J Radiat Oncol Biol Phys 94 544-464

[10] Folkesson J(2016)Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies Ann Surg 263 458-939

[1] Bosset JF(2006)EORTC Radiotherapy Group Trial 22921: Chemotherapy with preoperative radiotherapy in rectal cancer New Engl J Med 355 1114-1123

[2] Collette L(2006)Preoperative radiotherapy with ´ or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 4620-4625

[3] Calais G(2011)Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12- year follow-up of the multicentre, randomised controlled TME trial Lancet Oncol 12 575-582

[4] Gerard JP(2005)Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 5644-5650

[5] Conroy T(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[6] Bonnetain F(2012)Preoperative versus postoperative chemoradiotherapy for localy advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933

[7] Van Gijn W(2018)Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer J Surg Res 226 15-23

[8] Marijnen CA(1999)Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90–01 randomized trial J Clin Oncol 17 2396-553

[9] Nagtegaal ID(2016)Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90–01 Randomized Trial Int J Radiat Oncol Biol Phys 94 544-464

[10] Folkesson J(2016)Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies Ann Surg 263 458-939